Detalhe da pesquisa
1.
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper.
Br J Haematol
; 204(4): 1193-1206, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38393718
2.
Exercise prehabilitation for people with myeloma undergoing autologous stem cell transplantation: results from PERCEPT pilot randomised controlled trial.
Acta Oncol
; 62(7): 696-705, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36794394
3.
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study.
Lancet Oncol
; 23(1): 65-76, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34871550
4.
A UK consensus algorithm for early treatment modification in newly diagnosed systemic light-chain amyloidosis.
Br J Haematol
; 198(2): 328-332, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35509237
5.
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019.
Br J Haematol
; 197(1): 82-96, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35166376
6.
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy.
Br J Haematol
; 196(4): 892-901, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34761389
7.
Application of diffusion-weighted whole-body MRI for response monitoring in multiple myeloma after chemotherapy: a systematic review and meta-analysis.
Eur Radiol
; 32(4): 2135-2148, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35028748
8.
The impact of COVID-19 on autologous stem cell transplantation in multiple myeloma: A single-centre, qualitative evaluation study.
Support Care Cancer
; 30(9): 7469-7479, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35657402
9.
Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial.
Br J Haematol
; 194(1): 132-139, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33822368
10.
Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: results from a multicenter, phase II, randomized, controlled trial (MUKfive).
Haematologica
; 106(10): 2694-2706, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33910333
11.
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design.
Br J Cancer
; 123(2): 187-195, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32435057
12.
Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light-chain amyloidosis.
Br J Haematol
; 189(4): 643-649, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31984481
13.
Long term outcomes in monoclonal gammopathy of renal significance.
Br J Haematol
; 186(5): 706-716, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31141168
14.
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.
Br J Haematol
; 187(5): 638-641, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31388995
15.
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.
N Engl J Med
; 375(14): 1319-1331, 2016 10 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27705267
16.
Functional and psychological impact of minimal residual disease assessment on patients with multiple myeloma.
Br J Haematol
; 202(5): e43-e45, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37353905
17.
Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response.
Br J Haematol
; 176(2): 222-233, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27766627
18.
Real-world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi-centre UK experience.
Br J Haematol
; 176(6): 908-917, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28211054
19.
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.
Br J Haematol
; 196(3): e21-e26, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34632575
20.
Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial.
Br J Haematol
; 196(4): e33-e37, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34636043